Publications by authors named "Mathias Loft"

Claim this Profile
M
Marie Krogh's contributions to the study of thyroid physiology and pathophysiology.
Per Karkov Cramon, Mathias Loft, Ronan M G Berg

Exp Physiol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Human: Simultaneous Hyperpolarized 1- 13 C-Pyruvate Magnetic Resonance Spectroscopy and 18 F-FDG PET (hyperPET) Imaging of a Patient With Lymphoma.
Mathias Loft, Andreas Clemmensen, Emil Nørgaard Christensen, Charlotte Lund Denholt, Helle Hjorth Johannesen

Clin Nucl Med· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routine Use of [Cu]Cu-DOTATATE PET/CT in a Neuroendocrine Tumor Center: Referral Patterns and Image Results of 2,249 Consecutive Scans.
Esben Andreas Carlsen, Mathias Loft, Camilla Bardram Johnbeck, Ulrich Knigge, Seppo W Langer

J Nucl Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Not Available].
Mathias Loft, Helle Hjorth Johannesen, Sannia Sjöstedt, Annemette Abild-Nielsen, Hans Henrik Lawaetz Schultz

Ugeskr Laeger· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial for "Quantification of Prostate Cancer Metabolism Using 3D Multiecho bSSFP and Hyperpolarized [1- C] Pyruvate: Metabolism Differs Between Tumors of the Same Gleason Grade".
Andreas Clemmensen, Mathias Loft, Andreas Kjaer, Thomas Lund Andersen

J Magn Reson Imaging· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Investigation of Lesion Detection Accuracy for Artificial Intelligence-Based Denoising of Low-Dose Cu-DOTATATE PET Imaging in Patients with Neuroendocrine Neoplasms.
Mathias Loft, Claes N Ladefoged, Camilla B Johnbeck, Esben A Carlsen, Peter Oturai

J Nucl Med· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Phase II Trial of [Ga]Ga-NODAGA-E[c(RGDyK)] PET/CT Imaging of Integrin αβ for Prognostication in Patients with Neuroendocrine Neoplasms.
Esben Andreas Carlsen, Mathias Loft, Annika Loft, Dorota Czyzewska, Mikkel Andreassen

J Nucl Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using F-labeled Active-Site Inhibited Factor VII (F-ASIS): Potential as Companion Diagnostic.
Mathias Loft, Camilla Christensen, Malene M Clausen, Esben A Carlsen, Carsten P Hansen, Annika Loft

J Nucl Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Phase II Trial of Prognostication by Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy.
Esben Andreas Carlsen, Mathias Loft, Annika Loft, Anne Kiil Berthelsen, Seppo W Langer

J Nucl Med· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activity Dose Reduction in Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Impact on Image Quality and Lesion Detection Ability.
Mathias Loft, Esben A Carlsen, Camilla B Johnbeck, Christoffer V Jensen, Flemming L Andersen

Mol Imaging Biol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A convolutional neural network for total tumor segmentation in [Cu]Cu-DOTATATE PET/CT of patients with neuroendocrine neoplasms.
Esben Andreas Carlsen, Kristian Lindholm, Amalie Hindsholm, Mathias Gæde, Claes Nøhr Ladefoged, Mathias Loft

EJNMMI Res· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Factorial Phase II Study to Determine the Optimal Dosing Regimen for Ga-Satoreotide Trizoxetan as an Imaging Agent in Patients with Gastroenteropancreatic Neuroendocrine Tumors.
Irene Virgolini, Shadfar Bahri, Andreas Kjaer, Henning Grønbæk, Peter Iversen, Mathias Loft

J Nucl Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semiautomatic Tumor Delineation for Evaluation of Cu-DOTATATE PET/CT in Patients with Neuroendocrine Neoplasms: Prognostication Based on Lowest Lesion Uptake and Total Tumor Volume.
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Mathias Loft, Andreas Pfeifer, Peter Oturai

J Nucl Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ga]Ga-NODAGA-E[(cRGDyK)] Angiogenesis PET/MR in a Porcine Model of Chronic Myocardial Infarction.
Simon Bentsen, Andreas Clemmensen, Mathias Loft, Mette Flethøj, Karina Poulsdóttir Debes

Diagnostics (Basel)· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial Experience with Cu-DOTATATE Digital PET of Patients with Neuroendocrine Neoplasms: Comparison with Analog PET.
Mathias Loft, Camilla B Johnbeck, Esben A Carlsen, Helle H Johannesen, Peter Oturai

Diagnostics (Basel)· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cu-DOTATATE PET in Patients with Neuroendocrine Neoplasms: Prospective, Head-to-Head Comparison of Imaging at 1 Hour and 3 Hours After Injection.
Mathias Loft, Esben A Carlsen, Camilla B Johnbeck, Helle H Johannesen, Tina Binderup, Annika Loft

J Nucl Med· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cu-DOTATATE PET/CT and Prediction of Overall and Progression-Free Survival in Patients with Neuroendocrine Neoplasms.
Esben Andreas Carlsen, Camilla Bardram Johnbeck, Tina Binderup, Mathias Loft, Andreas Pfeifer, Annika Loft

J Nucl Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodality Hyperpolarized C-13 MRS/PET/Multiparametric MR Imaging for Detection and Image-Guided Biopsy of Prostate Cancer: First Experience in a Canine Prostate Cancer Model.
Sunitha V Bachawal, Jae Mo Park, Keerthi S Valluru, Mathias Dyrberg Loft, Stephen A Felt

Mol Imaging Biol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The CPC Risk Calculator: A New App to Predict Prostate-specific Antigen Recurrence During Follow-up After Radical Prostatectomy.
Martin Andreas Røder, Kasper Drimer Berg, Mathias Dyrberg Loft, Frederik Birkebæk Thomsen, Michelle Ferrari

Eur Urol Focus· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal Trends in Clinical and Pathological Characteristics for Men Undergoing Radical Prostatectomy Between 1995 and 2013 at Rigshospitalet, Copenhagen, Denmark, and Stanford University Hospital, United States.
Mathias Dyrberg Loft, Kasper Drimer Berg, Andreas Kjaer, Peter Iversen, Michelle Ferrari

Clin Genitourin Cancer· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved positron emission tomography imaging of glioblastoma cancer using novel Ga-labeled peptides targeting the urokinase-type plasminogen activator receptor (uPAR).
Mathias Dyrberg Loft, Yao Sun, Changhao Liu, Camilla Christensen, Daijuan Huang

Amino Acids· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Study on GRPR-Targeted (68)Ga-Probes for PET Imaging of Prostate Cancer.
Yao Sun, Xiaowei Ma, Zhe Zhang, Ziyan Sun, Mathias Loft

Bioconjug Chem· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis